NJ A3668 | 2024-2025 | Regular Session
Note: Carry Over of previous A2544
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 12 2024 - 25% progression
Action: 2024-02-12 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on February 12 2024 - 25% progression
Action: 2024-02-12 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.
Title
Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-02-12 | Assembly | Introduced, Referred to Assembly Financial Institutions and Insurance Committee |
Same As/Similar To
A2544 (Carry Over) 2022-02-14 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Subjects
New Jersey State Sources
| Type | Source |
|---|---|
| Summary | https://www.njleg.state.nj.us/bill-search/2024/A3668 |
| Text | https://pub.njleg.gov/Bills/2024/A4000/3668_I1.HTM |
